100
Views
0
CrossRef citations to date
0
Altmetric
Review

Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine

, &
Pages 123-128 | Published online: 05 Mar 2014

References

  • Silberstein SD . Migraine symptoms: results of a survey of self-reported migraineurs. Headache35(7) , 387–396 (1995).
  • Stovner L , HagenK, JensenR et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27 , 193–210 (2007).
  • Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia24(Suppl. 1) , 9–160 (2004).
  • Menken M , MunsatTL, TooleJF. The global burden of disease study: implications for neurology. Arch. Neurol.27 , 418–420 (2000).
  • Kelman L , TanisD. The relationship between migraine pain and other associated symptoms. Cephalalgia26 , 548–553 (2006).
  • Hawkins K , WangS, RupnowM. Direct cost burden among insured US employees with migraine. Headache48(4) , 553–563 (2008).
  • Hawkins K , WangS, RupnowMF. Indirect cost burden of migraine in the United States. J. Occup. Environ. Med.49(4) , 368–374 (2007).
  • Vikelis M , RapoportAM. New drug delivery options for migraine. Expert Rev. Neurother.11(6) , 771–773 (2011).
  • Vikelis M , RapoportAM. Overview of oral triptans. In: Triptans for Migraine. Diener HC, Dodick DW (Eds). Future Medicine eBooks, London, UK, 16–31 (2012).
  • Burstein R , LevyD, JakubowskiM. Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine. Rev. Neurol. (Paris)161(6–7) , 658–660 (2005).
  • Rapoport AM , FreitagF, PearlmanSH. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine. CNS Drugs24(11) , 929–940 (2010).
  • Tepper SJ , MillsonD. Safety profile of the triptans. Expert Opin. Drug Saf.2(2) , 123–132 (2003).
  • Fuseau E , PetricoulO, MooreKHP et al. Clinical pharmacokinetics of intranasal sumatriptan. Clin. Pharmacokinet. 41 , 801–811 (2002).
  • Uemura N , OnishiT, MitaniyamaA et al. Bioequivalence and rapid absorption of zolmitriptan nasal spray compared with oral tablets in healthy Japanese subjects. Clin. Drug Investig. 25(3) , 199–208 (2005).
  • Dowson A , BundyM, SaltR, KilminsterS. Patient preference for triptan formulations: a prospective study with zolmitriptan. Headache47(8) , 1144–1151 (2007).
  • Vikelis M , MitsikostasDD, RapoportAM. Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine. Neuropsychiatr. Dis. Treat.8 , 429–434 (2012).
  • Ferrari MD , SaxenaPR. On serotonin and migraine: a clinical and pharmacological review. Cephalalgia13(3) , 151–165 (1993).
  • Siegel SJ , O‘NeillC, DubeLM et al. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. Headache 47(5) , 753 (2007).
  • Pierce M , MarburyT, O‘NeillC, SiegelS, DuW, SebreeT. Zelrix: a novel transdermal formulation of sumatriptan. Headache49(6) , 817–825 (2009).
  • Aurora S , KoriS, BarrodaleP, NelsenA, McDonaldS. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache47(10) , 1443–1446 (2007).
  • Goldstein J , PugachN, SmithT, NettR, AngelovAS, PierceMW. Acute anti-migraine efficacy and tolerability of Zelrix™, a novel iontophoretic transdermal patch of sumatriptan. Presented at: the 14th Congress of International Headache Society. Phildelphia, PA, USA, 10–13 September 2009.
  • Goldstein J , PugachN, SmithTR. Acute anti-migraine efficacy and tolerability of Zelrix, a novel iontophoretic transdermal patch of sumatriptan. Cephalalgia29(Suppl. 1) , 20 (2009).
  • Pierce MW . Transdermal delivery of sumatriptan for the treatment of acute migraine. Neurotherapeutics7(2) , 159–163 (2010).
  • Schulman E . Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea. Headache52 , 204–212 (2012).
  • Derry CJ , DerryS, MooreRA. Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults. Cochrane Database Syst. Rev.2 , CD009665 (2012).
  • Derry CJ , DerryS, MooreRA. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst. Rev.2 , CD008615 (2012).
  • Smith T , GoldsteinJ, SingerR, PugachN, SilbersteinS, PierceM. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system. Headache52 , 612–624 (2012).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.